medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 2

<< Back Next >>

Rev Mex Urol 2008; 68 (2)

Female Sexual Dysfunction (FSD) prevalence in a Urology Center population

Pérez-Martínez C, Vargas-Díaz IB, Cisneros-Castolo M
Full text How to cite this article

Language: Spanish
References: 12
Page: 98-102
PDF size: 188.03 Kb.


Key words:

Female Sexual Dysfunction, Urological Consultation, Prevalence, Female Orgasm.

ABSTRACT

Sexual dysfunction affects approximately 43% of women and 31% of men. Despite the existence of the concept of equality of the sexes including the area of Sexual Rights, there is no epidemiological information on Female Sexual Dysfunction (FSD) in Mexico. A few regional reports relating FSD with urinary incontinence have been made. Previously published studies report that 68.6% of women have satisfying sexual relations.
Objective: To study FSD prevalence in the female patient and non-patient population of a specific Urology Service.
Materials and Methods: A sexuality questionnaire was distributed to all women entering our medical center, whether as patients or persons accompanying the patients. The Female Sexual Function Index (FSFI) questionnaire was applied using the consecutive non-random technique. Data were collected in an Excel Database and processed by X2. CI was 95% and the results were analyzed with the SPSS statistics program.
Results: Only 44 questionnaires were completed. The mean age was 30.45 years (range from 17-49 years). Of these cases, 9/44 women (20.45%) reported low or inexistent sexual desire; 12/44 women (27.27%) reported low sexual arousal, 11/44 women (25%) reported difficulty maintaining lubrication, 15/44 women (34.09%) were anorgasmic, 8/44 women (18.18%) reported dyspareunia and 3/44 women (6.81%) had reduced sensitivity in the area of the clitoris. Twenty-five per cent (11/44) of women surveyed complained of a lack of sexual satisfaction compared with 38.63% (17/44) of women who recognized that they presented with some type of sexual dysfunction. However, only 11.36% (5/44) of women expressed a desire to receive help in resolving the problem. In relation to marital status, the FSD relative risk was 2.2 among married women (95% CI, P=›0.000). The age average among women not presenting with FSD was 26.6 years (range from 16-44 years) and the age average among women presenting with FSD was 36.34 years (range from 24-49 years). There was statistical significance (P =‹0.05).
Conclusions: There was a 34% FSD prevalence in this group and age and marital status were the most important factors. Anorgasmia was the most frequent sexual dysfunction, but only 11.36% of presenting women expressed a desire to seek help for it.


REFERENCES

  1. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000;2(3):189-95.

  2. Salonia A, Zanni G, Nappi RE, Briganti A, Deho F et al. Sexual dysfunction is Common in Women with Lower Urinary Tract Symptoms and Urinary Incontinence. Eur Urol 2004;45:642-648.

  3. 2nd ICUD-WHO International Consultation on Erectile and Sexual Dysfunctions, Paris, France. 28 June-1st July, 2003.

  4. Perez-Martinez C, Vargas-Diaz IB & Cisneros-Castolo M. Increase of Sexual Performance in Women Under Extracorporeal Magnetic Innervation as Therapy for Urinary Incontinence. Progrés en Urologie 2003;13:Sup 2, abs 10.

  5. Rosen R, Taylor J, Leiblum S, Bachmann G. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological. J Sex Marital Ther 1999;19(3):171.

  6. Bechara A, Bertolino MV, Casabe A, Munarriz R, Goldstein I, Morin A, Secin F, Literat B, Pesaresi M, Fredotovich N. Duplex Doppler ultrasound assessment of clitoral hemodynamics after topical administration of alprostadil in women with arousal and orgasmic disorders. J Sex Marital Ther 2003;29 S1:1-10.

  7. Bechara A, Morin A, Casabé A, Bertolino M, Katz B, Secin F, Pesaresi M, Fredotovich N. Disfunción Sexual Femenina: prevalencia en la consulta ginecológica. Abstract Congreso Argentino de Urología, XXX Congreso de la Confederación Argentina de Urología. Buenos Aires, 2001.

  8. Bechara A. Female sexual prevalence in Argentina. In: Abstracts from New Perspectives in the Management of Female Sexual Dysfunction. Boston, 2000, Site: http://www.isswsh.org.

  9. Moncada I. Testosterone and men’s quality of life. Aging Male 2006;9(4):189-93.

  10. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J et al. Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications. J Urol 2000;163:888-893.

  11. Perez-Martinez C, Vargas-Diaz IB & Cisneros-Castolo M. Prevalence of female sexual dysfunction (FSD) in an attending urological unit population. J Sex Med 2004;S1:Abstract

  12. Rosen R. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2008;68